There was benefit, but it was very small, only cutting the risk by a fraction of a percentage point. I had developed multiple autoimmune issues on Anastrozole and was miserable. So my oncologist didn’t think it made sense to chase that last fraction of a percentage point and neither did I. My issues have all resolved since I’ve been off the Anastrozole so for me it was the right decision.